Company: RNAC
Filing Date: 2025-01-08
Form Type: 424B7
Source: 0001140361-25-000634
Chunk: 27

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-01-08
Form: 424B7
Chunk 27
---
 Total Aggregate 
  Purchase Price |
| Timothy A. Springer, Ph.D.                                 |     |                    1,636,832 |     |     $32,736,640 |
| TAS Partners LLC (affiliate of Timothy A. Springer, Ph.D.) |     |                      721,361 |     |     $14,427,220 |
| Chafen Lu, Ph.D.                                           |     |                        1,307 |     |         $26,140 |

In connection with the 2024 Private Placement, we entered into the 2024 RRA with Dr. Springer, TAS, Dr. Lu and the purchasers of shares of Series B Preferred Stock and Common Stock. Warrant Exercise On March 26, 2024, TAS exercised 65,681 warrants originally issued in 2019 (and amended in December 2022), paid the per-share exercise price of $43.80 in cash for an aggregate exercise price of $2.9 million, and received 65,681 shares of Common Stock and 1,970,443 CVRs. 2023 Private Placement In the 2023 Private Placement, we entered into the Securities Purchase Agreement pursuant to which we issued and sold an aggregate of 149,330.115 shares of Series A Preferred Stock, each of which was converted or is convertible into 33.333 shares of Common Stock, for an aggregate purchase price of approximately $60.25 million. Timothy A. Springer, Ph.D., one of the Selling Stockholders and a member of our Board of Directors, participated in the 2023 Private Placement and was party to the 2023 RRA. TAS is affiliated with Dr. Springer and TAS also participated in the 2023 Private Placement and was party to the 2023 RRA. The Trust is affiliated with Murat Kalayoglu, M.D., Ph.D., a member of our Board of Directors, and participated in the 2023 Private Placement and was party to the 2023 RRA. The following table sets forth the number of shares of Series A Preferred Stock purchased in the 2023 Private Placement by such parties:

| Name                                                                                     |     | Shares of Series A Preferred 
              Stock Purchased |     | Total Aggregate 
  Purchase Price |
| Timothy A. Springer, Ph.D.                                                               |     |                  123,925.407 |     |     $50,000,000 |
| TAS Partners LLC (affiliate of Timothy A. Springer, Ph.D.)                               |